Category: ODD/BTA/FTA Status Region: North America · United States Company: Astrazeneca Pharmaceuticals Inc

AZ announces US fast track designation for IL-5 inhibitor Fasenra

AZ announces US fast track designation for IL-5 inhibitor Fasenra
AstraZeneca

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!